US Test Reactors Achieve Milestones in Advanced Nuclear Development The U.S. Department of Energy (DOE) has marked significant progress in its Reactor Pilot Program, with multiple advanced nuclear projects reaching criticality milestones. Among these, Oklo’s Grove reactor, located near Lockhart in Caldwell County, Texas, achieved initial criticality ahead of schedule, becoming a key example of accelerated nuclear innovation. The program, launched under President Donald Trump’s executive order in May 2025, aimed to construct, operate, and achieve criticality of at least three test reactors by 4 July 2026. Grove’s success, announced in early July, underscores the program’s goal of streamlining the authorization process for advanced reactor designs. Oklo’s Grove, a low-power test reactor, was one of 11 projects selected by the DOE in August 2025 for the Reactor Pilot Program. The reactor, developed from a greenfield site on private land, represents a breakthrough in domestic nuclear deployment. Oklo’s CEO, Jacob DeWitte, highlighted the project’s achievements, stating, “Reaching criticality in less than a year is an incredible milestone for our team.” The company’s efforts included full-scale civil excavation, component manufacturing, and in-house development of operational protocols, setting a new benchmark for the program. Grove’s primary purpose is to demonstrate reactor design, construction, and operational capabilities, while also supporting future isotope production facilities critical for medical, industrial, and scientific applications. The milestone marks a critical step toward Oklo’s broader vision of domestic isotope production, which could revolutionize fields such as cancer treatment, manufacturing, and space exploration.#us_department_of_energy #jacob_dewitte #oklo_grove #reactor_pilot_program #deep_fission
Oklo Shares Drop 9.1% Amid Earnings Miss and Insider Sales Oklo Inc. (NYSE:OKLO) shares fell 9.1% during mid-day trading on Monday, hitting a low of $44.88 before closing at $45.68. The stock traded around 10.64 million shares, slightly above the average daily volume of 10.44 million. The decline followed a quarterly earnings report that missed expectations, with the company reporting an EPS of ($0.27) versus the anticipated ($0.17). This marked a significant underperformance, as Oklo’s earnings for the same period last year were ($0.74) per share. Analysts have since adjusted their price targets, with Citigroup lowering its forecast to $73.50 from $95.00 and Barclays cutting its target to $82.00 from $146.00. Despite mixed sentiment, the consensus rating remains a "Moderate Buy" with a $84.30 price target. The stock’s performance has been further impacted by insider selling. Over the past quarter, insiders sold a total of 1,222,424 shares worth approximately $100.7 million. Notably, the CEO, Jacob Dewitte, sold 231,657 shares at an average price of $99.25, totaling $22.99 million, reducing his ownership by 21.88%. Similarly, CFO Richard Craig Bealmear sold 72,090 shares at $60.00 each, generating $4.33 million, and his stake decreased by 15.74%. These transactions have raised concerns among investors, as significant insider selling often signals potential negative outlooks. Wall Street analysts have provided a range of opinions on Oklo’s stock. Cantor Fitzgerald reaffirmed an "overweight" rating with a $122.00 price target, while Weiss Ratings issued a "sell (d)" rating. Texas Capital upgraded the stock to a "strong-buy" rating, and several firms, including Citigroup and Barclays, have adjusted their recommendations.#oklo_inc #jacob_dewitte #richard_craig_bealmear #cantor_fitzgerald #weiss_ratings
